These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 8216404)
1. In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases. Wittenberg RH; Willburger RE; Kleemeyer KS; Peskar BA Arthritis Rheum; 1993 Oct; 36(10):1444-50. PubMed ID: 8216404 [TBL] [Abstract][Full Text] [Related]
2. [Prostaglandin and leukotriene release of synovial tissue in various joint diseases]. Wittenberg RH; Willburger RE; Kleemeyer KS; Schleberger R Z Orthop Ihre Grenzgeb; 1991; 129(6):531-6. PubMed ID: 1837403 [TBL] [Abstract][Full Text] [Related]
3. [Effect of sulfasalazine and its metabolites on prostaglandin and leukotriene liberation from human synovial tissue]. Wittenberg HR; Kleemeyer K; Peskar BM; Peskar BA Wien Klin Wochenschr; 1991; 103(2):34-9. PubMed ID: 1673814 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of eicosanoid release from synovial organ culture by incubation with tepoxalin and its acid metabolite. Willburger RE; Wittenberg RH; Kleemeyer KS; Hoos R; Brunner-Ferber FL; Peskar BA Prostaglandins; 1996 Oct; 52(4):327-38. PubMed ID: 8936587 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of arachidonate oxidation products by synovial joint tissues during the development of chronic erosive arthritis. Henderson B; Higgs GA Arthritis Rheum; 1987 Oct; 30(10):1149-56. PubMed ID: 2823836 [TBL] [Abstract][Full Text] [Related]
6. Antiinflammatory effect of tepoxalin: blood and synovial tissue studied in patients with knee arthrosis. Willburger RE; Wittenberg RH; Schmidt K; Kleemeyer KS; Peskar BA Acta Orthop Scand; 1998 Jun; 69(3):295-300. PubMed ID: 9703407 [TBL] [Abstract][Full Text] [Related]
7. Involvement of prostaglandins from rheumatoid synovium in inhibition of articular cartilage metabolism. Lippiello L; Yamamoto K; Robinson D; Mankin HJ Arthritis Rheum; 1978; 21(8):909-17. PubMed ID: 737014 [TBL] [Abstract][Full Text] [Related]
8. [Leukotriene B4, leukotriene C4 and prostaglandin E2 in the serum, synovial fluid and synovium in patients with rheumatoid arthritis]. Sawazaki Y Nihon Ika Daigaku Zasshi; 1989 Dec; 56(6):559-64. PubMed ID: 2558123 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of interleukin 1beta, tumor necrosis factor-alpha, and interstitial collagenase (MMP-1) is eicosanoid dependent in human osteoarthritis synovial membrane explants: interactions with antiinflammatory cytokines. He W; Pelletier JP; Martel-Pelletier J; Laufer S; Di Battista JA J Rheumatol; 2002 Mar; 29(3):546-53. PubMed ID: 11908571 [TBL] [Abstract][Full Text] [Related]
10. Low dose methotrexate decreases intraarticular prostaglandin and interleukin 1 levels in antigen induced arthritis in rabbits. Novaes GS; Mello SB; Laurindo IM; Cossermelli W J Rheumatol; 1996 Dec; 23(12):2092-7. PubMed ID: 8970046 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of PGE2 production by nimesulide compared with diclofenac in the acutely inflamed joint of patients with arthritis. Duffy T; Belton O; Bresnihan B; FitzGerald O; FitzGerald D Drugs; 2003; 63 Suppl 1():31-6. PubMed ID: 14506909 [TBL] [Abstract][Full Text] [Related]
12. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Woolley DE; Tetlow LC Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391 [TBL] [Abstract][Full Text] [Related]
13. Prostaglandins in the rheumatic diseases. Robinson DR; McGuire MB; Levine L Ann N Y Acad Sci; 1975 Jun; 256():318-29. PubMed ID: 169722 [TBL] [Abstract][Full Text] [Related]
14. Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis. Mânsson B; Gülfe A; Geborek P; Heinegård D; Saxne T Ann Rheum Dis; 2001 Jan; 60(1):27-31. PubMed ID: 11114278 [TBL] [Abstract][Full Text] [Related]
15. Eicosanoid production in rheumatoid synovitis. Moilanen E; Alanko J; Nissilä M; Hämäläinen M; Isomäki H; Vapaatalo H Agents Actions; 1989 Nov; 28(3-4):290-7. PubMed ID: 2556902 [TBL] [Abstract][Full Text] [Related]
16. Intercellular messengers in joint tissues in rheumatoid arthritis. How disturbed control mechanisms may contribute to tissue destruction and repair. Russell RG; McGuire MK; Meats JE; Ebsworth NM; Beresford J Scand J Rheumatol Suppl; 1981; 40():75-87. PubMed ID: 6100920 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of SPARC (osteonectin) synthesis in arthritic cartilage. Increased levels in synovial fluids from patients with rheumatoid arthritis and regulation by growth factors and cytokines in chondrocyte cultures. Nakamura S; Kamihagi K; Satakeda H; Katayama M; Pan H; Okamoto H; Noshiro M; Takahashi K; Yoshihara Y; Shimmei M; Okada Y; Kato Y Arthritis Rheum; 1996 Apr; 39(4):539-51. PubMed ID: 8630101 [TBL] [Abstract][Full Text] [Related]
18. Tissue concentration of the active substance of Voltaren SR 75 in articular cartilage, synovial membrane and bone. Bender T; Schäfer M; Bariska J Clin Rheumatol; 2000; 19(2):89-91. PubMed ID: 10791617 [TBL] [Abstract][Full Text] [Related]
19. Toxoplasma gondii alters eicosanoid release by human mononuclear phagocytes: role of leukotrienes in interferon gamma-induced antitoxoplasma activity. Yong EC; Chi EY; Henderson WR J Exp Med; 1994 Nov; 180(5):1637-48. PubMed ID: 7964451 [TBL] [Abstract][Full Text] [Related]
20. Role of eicosanoids in structural degradation in osteoarthritis. Laufer S Curr Opin Rheumatol; 2003 Sep; 15(5):623-7. PubMed ID: 12960491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]